198 related articles for article (PubMed ID: 10078646)
1. The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinoma.
Li JH; Lax SA; Kim J; Klamut H; Liu FF
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):607-16. PubMed ID: 10078646
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effects of Ad5CMV-p53 expression in two human nasopharyngeal carcinoma cell lines.
Li JH; Li P; Klamut H; Liu FF
Clin Cancer Res; 1997 Apr; 3(4):507-14. PubMed ID: 9815713
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma.
Weinrib L; Li JH; Donovan J; Huang D; Liu FF
Cancer Gene Ther; 2001 May; 8(5):352-60. PubMed ID: 11477455
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral p53 gene therapy promotes heat-induced apoptosis in a nasopharyngeal carcinoma cell line.
Qi V; Weinrib L; Ma N; Li JH; Klamut H; Liu FF
Int J Hyperthermia; 2001; 17(1):38-47. PubMed ID: 11212879
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines.
Parker LP; Wolf JK; Price JE
Ann Clin Lab Sci; 2000 Oct; 30(4):395-405. PubMed ID: 11045764
[TBL] [Abstract][Full Text] [Related]
6. p16 gene therapy: a potentially efficacious modality for nasopharyngeal carcinoma.
Lee AW; Li JH; Shi W; Li A; Ng E; Liu TJ; Klamut HJ; Liu FF
Mol Cancer Ther; 2003 Oct; 2(10):961-9. PubMed ID: 14578461
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
8. Enhanced therapeutic efficacy of adenovirus-mediated interleukin-24 gene therapy combined with ionizing radiotherapy for nasopharyngeal carcinoma.
Liu J; Zhang Y; Sun P; Xie Y; Xiang J; Yang J
Oncol Rep; 2013 Sep; 30(3):1165-74. PubMed ID: 23783436
[TBL] [Abstract][Full Text] [Related]
9. Additional gene therapy with Ad5CMV-p53 enhanced the efficacy of radiotherapy in human prostate cancer cells.
Sasaki R; Shirakawa T; Zhang ZJ; Tamekane A; Matsumoto A; Sugimura K; Matsuo M; Kamidono S; Gotoh A
Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1336-45. PubMed ID: 11728695
[TBL] [Abstract][Full Text] [Related]
10. Combined radiation and p53 gene therapy of malignant glioma cells.
Badie B; Goh CS; Klaver J; Herweijer H; Boothman DA
Cancer Gene Ther; 1999; 6(2):155-62. PubMed ID: 10195882
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated wild-type p53 gene expression radiosensitizes non-small cell lung cancer cells but not normal lung fibroblasts.
Kawabe S; Munshi A; Zumstein LA; Wilson DR; Roth JA; Meyn RE
Int J Radiat Biol; 2001 Feb; 77(2):185-94. PubMed ID: 11236925
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-p53 gene therapy in human nasopharyngeal carcinoma xenografts.
Lax SA; Chia MC; Busson P; Klamut HJ; Liu FF
Radiother Oncol; 2001 Dec; 61(3):309-12. PubMed ID: 11731001
[TBL] [Abstract][Full Text] [Related]
13. p21WAF1/CIP1 is more effective than p53 in growth suppression of mouse renal carcinoma cell line Renca in vitro and in vivo.
Kralj M; Pavelić J
J Cancer Res Clin Oncol; 2003 Aug; 129(8):463-71. PubMed ID: 12884025
[TBL] [Abstract][Full Text] [Related]
14. [Apoptotic effect of bcl-XL antisense oligodeoxynucleotide mediated by lipofectin on cell strain CNE-2Z].
He GR; Zhou KY; Cai KR; Liang T; He CW; Zhang YF
Ai Zheng; 2003 Jan; 22(1):11-5. PubMed ID: 12561428
[TBL] [Abstract][Full Text] [Related]
15. [Adenovirus-mediated interleukin-24 enhanced the antitumor effect of radiotherapy on nasopharyngeal carcinoma in vitro and in vivo].
Sun P; Yang JC; Xie YF; Sheng WH; Liu JS
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 48(11):942-50. PubMed ID: 24444642
[TBL] [Abstract][Full Text] [Related]
16. Preclinical study of adenoviral p53 gene therapy for esophageal cancer.
Shimada H; Shimizu T; Ochiai T; Liu TL; Sashiyama H; Nakamura A; Matsubara H; Gunji Y; Kobayashi S; Tagawa M; Sakiyama S; Hiwasa T
Surg Today; 2001; 31(7):597-604. PubMed ID: 11495154
[TBL] [Abstract][Full Text] [Related]
17. Inducing apoptosis of human nasopharyngeal carcinoma cell line CNE-2Z by bcl-xL short hairpin RNA.
He CW; Liu F; Zhang YF; Liang T; Zhou KY
Ai Zheng; 2005 Jun; 24(6):646-52. PubMed ID: 15946471
[TBL] [Abstract][Full Text] [Related]
18. [Synergistic tumor suppression by Ad. RGD-iNG4 in human nasopharyngeal carcinoma cell CNE and its mechanism].
Wang Y; Sheng W; Yang J; Liu J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Mar; 28(6):410-5. PubMed ID: 24961131
[TBL] [Abstract][Full Text] [Related]
19. The effect of p21 antisense oligodeoxynucleotides on the radiosensitivity of nasopharyngeal carcinoma cells with normal p53 function.
Liu XF; Xia YF; Li MZ; Wang HM; He YX; Zheng ML; Yang HL; Huang WL
Cell Biol Int; 2006 Mar; 30(3):283-7. PubMed ID: 16448826
[TBL] [Abstract][Full Text] [Related]
20. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) exhibits p53-dependent and -independent antiproliferative activity in human nasopharyngeal carcinoma cells in vitro and in vivo.
Nguyen TH; Ong CK; Wong E; Leong CT; Panasci L; Huynh H
Int J Oncol; 2005 Oct; 27(4):1131-40. PubMed ID: 16142332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
